Evaluation of deep learning based implanted fiducial markers tracking in pancreatic cancer patients.


Journal

Biomedical physics & engineering express
ISSN: 2057-1976
Titre abrégé: Biomed Phys Eng Express
Pays: England
ID NLM: 101675002

Informations de publication

Date de publication:
07 03 2023
Historique:
received: 24 11 2022
accepted: 23 01 2023
pubmed: 24 1 2023
medline: 9 3 2023
entrez: 23 1 2023
Statut: epublish

Résumé

Real-time target position verification during pancreas stereotactic body radiation therapy (SBRT) is important for the detection of unplanned tumour motions. Fast and accurate fiducial marker segmentation is a Requirement of real-time marker-based verification. Deep learning (DL) segmentation techniques are ideal because they don't require additional learning imaging or prior marker information (e.g., shape, orientation). In this study, we evaluated three DL frameworks for marker tracking applied to pancreatic cancer patient data. The DL frameworks evaluated were (1) a convolutional neural network (CNN) classifier with sliding window, (2) a pretrained you-only-look-once (YOLO) version-4 architecture, and (3) a hybrid CNN-YOLO. Intrafraction kV images collected during pancreas SBRT treatments were used as training data (44 fractions, 2017 frames). All patients had 1-4 implanted fiducial markers. Each model was evaluated on unseen kV images (42 fractions, 2517 frames). The ground truth was calculated from manual segmentation and triangulation of markers in orthogonal paired kV/MV images. The sensitivity, specificity, and area under the precision-recall curve (AUC) were calculated. In addition, the mean-absolute-error (MAE), root-mean-square-error (RMSE) and standard-error-of-mean (SEM) were calculated for the centroid of the markers predicted by the models, relative to the ground truth. The sensitivity and specificity of the CNN model were 99.41% and 99.69%, respectively. The AUC was 0.9998. The average precision of the YOLO model for different values of recall was 96.49%. The MAE of the three models in the left-right, superior-inferior, and anterior-posterior directions were under 0.88 ± 0.11 mm, and the RMSE were under 1.09 ± 0.12 mm. The detection times per frame on a GPU were 48.3, 22.9, and 17.1 milliseconds for the CNN, YOLO, and CNN-YOLO, respectively. The results demonstrate submillimeter accuracy of marker position predicted by DL models compared to the ground truth. The marker detection time was fast enough to meet the requirements for real-time application.

Identifiants

pubmed: 36689758
doi: 10.1088/2057-1976/acb550
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2023 IOP Publishing Ltd.

Auteurs

Abdella M Ahmed (AM)

Northern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards, NSW, Australia.
School of Health Sciences, Faculty of Medicine and Health, University of Sydney, Australia.

Maegan Gargett (M)

Northern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards, NSW, Australia.
School of Health Sciences, Faculty of Medicine and Health, University of Sydney, Australia.

Levi Madden (L)

Northern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards, NSW, Australia.
ACRF Image X Institute, Faculty of Medicine and Health, The University of Sydney, NSW Australia.

Adam Mylonas (A)

ACRF Image X Institute, Faculty of Medicine and Health, The University of Sydney, NSW Australia.

Danielle Chrystall (D)

Northern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards, NSW, Australia.
Institute of Medical Physics, School of Physics, The University of Sydney, NSW, Australia.

Ryan Brown (R)

Northern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards, NSW, Australia.

Adam Briggs (A)

Shoalhaven Cancer Care Centre, Shoalhaven District Memorial Hospital, Nowra, NSW, Australia.

Trang Nguyen (T)

ACRF Image X Institute, Faculty of Medicine and Health, The University of Sydney, NSW Australia.

Paul Keall (P)

ACRF Image X Institute, Faculty of Medicine and Health, The University of Sydney, NSW Australia.

Andrew Kneebone (A)

Northern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards, NSW, Australia.
Northern Clinical School, Sydney Medical School, University of Sydney, NSW, Australia.

George Hruby (G)

Northern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards, NSW, Australia.
Northern Clinical School, Sydney Medical School, University of Sydney, NSW, Australia.

Jeremy Booth (J)

Northern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards, NSW, Australia.
Institute of Medical Physics, School of Physics, The University of Sydney, NSW, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH